You just read:

Oblique Therapeutics Present Tumor Growth Inhibition and Treg-lowering Data for OT-1096 in Humanized Mouse TNBC Model at Oncology Congress ESMO

News provided by

Oblique Therapeutics AB

09 Oct, 2018, 08:16 BST